Tailored Messaging for CRC Screening
Patient-directed Messaging to Increase Colorectal Cancer Screening
1 other identifier
interventional
600
1 country
1
Brief Summary
This is a randomized controlled trial to to determine whether direct, tailored messaging to patients prior to scheduling colonoscopy will increase patient adherence to provider recommendation for screening colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable colorectal-cancer
Started Oct 2017
Longer than P75 for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2017
CompletedStudy Start
First participant enrolled
October 9, 2017
CompletedFirst Posted
Study publicly available on registry
October 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedOctober 4, 2023
October 1, 2023
5.7 years
October 5, 2017
October 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Colonoscopy completion rate
The ratio of the number of participants who complete a colonoscopy to the total number of enrolled participants
120 days
Secondary Outcomes (1)
Colonoscopy scheduling rate
120 days
Study Arms (3)
Usual Care
NO INTERVENTIONParticipants in this arm will Usual scheduling process without any intervention
Generic Message
EXPERIMENTALParticipants in this arm will receive a telephone call from a study team member, and if no answer, up to two additional attempts will be made. During the telephone call, the study team member will ask the participant a series of 7 questions then receive a "generic" message encouraging colonoscopy scheduling.
Tailored Message
EXPERIMENTALParticipants in this arm will receive a telephone call from a study team member, and if no answer, up to two additional attempts will be made. During the telephone call, the participant will answer a series of 7 questions then receive a "tailored" message encouraging colonoscopy scheduling, which will be determined by their responses to the preceding questions.
Interventions
Eligibility Criteria
You may qualify if:
- University of Pennsylvania Health System (UPHS) patients with an active order for screening or surveillance colonoscopy without an existing colonoscopy appointment
- years of age
- Due for CRC screening or surveillance (defined as no evidence of: colonoscopy in the past 5 years, fecal immunochemical testing in the past 12 months, flexible sigmoidoscopy or CT colonography in the past 5 years, stool DNA test or Cologuard in the last 3 years)
You may not qualify if:
- Age \<50 or \>75
- Pregnant woman
- Evidence of prior colonoscopy in the past 5 years, fecal immunochemical testing in the past 12 months, flexible sigmoidoscopy or CT colonography in the past 5 years, fecal DNA test or Cologuard in the last 3 years
- History of colorectal cancer
- History of inflammatory bowel disease (Crohn's disease or Ulcerative colitis)
- History of colon surgery or resection
- History of symptoms concerning for colorectal cancer, such as lower GI bleeding, within the past 6 months
- Family history of a hereditary colorectal cancer syndrome, such as familial adenomatous polyposis (FAP) or hereditary non-polyposis colon cancer (HNPCC)
- Current serious medical condition with estimated life expectancy of less than 6 months, such as incurable cancer, end-stage congestive heart failure, decompensated cirrhosis, end stage renal disease, etc.
- Dementia
- Does not speak English
- No telephone number listed in electronic medical record
- Has any other condition that, in the opinion of the investigator, excludes the patient from participating in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pennsylvania Health System
Philadelphia, Pennsylvania, 19104, United States
Related Publications (1)
Oyalowo A, Forde KA, Lamanna A, Kochman ML. Effect of Patient-Directed Messaging on Colorectal Cancer Screening: A Randomized Clinical Trial. JAMA Netw Open. 2022 Mar 1;5(3):e224529. doi: 10.1001/jamanetworkopen.2022.4529.
PMID: 35357457DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael L Kochman, MD
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2017
First Posted
October 16, 2017
Study Start
October 9, 2017
Primary Completion
June 30, 2023
Study Completion
October 1, 2023
Last Updated
October 4, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share